Cargando…
COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel
Autores principales: | Yekutiel, Naama, Chodick, Gabriel, Tene, Lilac, Bronstein, Yotam, Grunspan, Moshe, Rivlin, Noa, Ofek, Keren, Cohen, Raanan, Raskin, Leon, Komlosi, Viktor, Herishanu, Yair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894345/ https://www.ncbi.nlm.nih.gov/pubmed/36751514 http://dx.doi.org/10.1097/HS9.0000000000000839 |
Ejemplares similares
-
P651: REAL-WORLD EFFECTIVENESS OF VENETOCLAX-BASED REGIMENS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN ISRAEL: UPDATE FROM THE MULTICENTER PROSPECTIVE REVEAL STUDY
por: Herishanu, Yair, et al.
Publicado: (2023) -
The Outcomes of Covid-19 in Patients with CLL during the Omicron Sub-Variants Surge
por: Bronstein, Yotam, et al.
Publicado: (2022) -
Hemato-oncology Tourism in Israel: A Retrospective Review
por: Hod, Keren, et al.
Publicado: (2020) -
Spatial organization and early signaling of the B-cell receptor in CLL
por: Shorer Arbel, Yamit, et al.
Publicado: (2022) -
CLL and COVID-19: light at the end of the tunnel?
por: Scarfò, Lydia, et al.
Publicado: (2022)